A TSH level above 10 mIU/L is the widely accepted threshold for starting thyroid medication. At that level, both the American Thyroid Association and the American Association of Clinical Endocrinology recommend treatment with levothyroxine regardless of symptoms. Below 10, the decision becomes more nuanced and depends on your age, symptoms, antibody status, and whether you’re pregnant or planning to become pregnant.
The 10 mIU/L Threshold
The normal TSH range for most adults falls between roughly 0.4 and 4.5 mIU/L. When TSH climbs above 10, you have what doctors consider more severe subclinical or overt hypothyroidism, and treatment is straightforward: you start levothyroxine, a synthetic version of the hormone your thyroid isn’t producing enough of. At this level, there’s clear evidence of increased cardiovascular risk and a high likelihood of progressing to full-blown hypothyroidism if left untreated.
In double-blinded randomized controlled trials, treating people whose TSH is below 10 has not consistently improved symptoms or cognitive function. That’s the main reason guidelines draw the line where they do. Above 10, the benefits of medication are well established. Below it, you and your doctor weigh several other factors.
When Medication Makes Sense Below 10
A TSH between 4.5 and 10 mIU/L with a normal free T4 level is called subclinical hypothyroidism. “Subclinical” means your lab numbers are off but you may or may not feel anything wrong. About 3 to 8 percent of the general population falls into this range, so it’s a common finding on routine bloodwork.
Even though guidelines don’t recommend blanket treatment below 10, medication is considered appropriate in several specific situations:
- You have hypothyroid symptoms. Fatigue, unexplained weight gain, cold intolerance, constipation, dry skin, hair loss, brain fog, or menstrual irregularities all count. If your TSH is elevated and you’re clearly symptomatic, your doctor may offer a trial of levothyroxine to see if your symptoms improve.
- You test positive for TPO antibodies. These antibodies indicate Hashimoto’s thyroiditis, an autoimmune condition that attacks the thyroid. People with positive TPO antibodies and a mildly elevated TSH are significantly more likely to progress to overt hypothyroidism over time, so early treatment can head that off.
- Your TSH is between 7 and 10. This range carries a measurable increase in stroke risk and coronary artery disease mortality, particularly in adults under 65. Some guidelines recommend treatment here even without obvious symptoms.
- Your TSH is rising over time. A TSH that was 5 a year ago and is now 7 suggests your thyroid function is declining. That trend, especially combined with TPO antibodies, strengthens the case for starting medication sooner.
- You have a goiter. An enlarged thyroid gland alongside elevated TSH is another reason to treat, as levothyroxine can help reduce gland size.
For a TSH in the 4.5 to 6.9 range with no symptoms, no antibodies, and no other risk factors, monitoring every 6 to 12 months is the typical approach rather than jumping to medication.
Pregnancy Changes the Rules
If you’re pregnant or planning to become pregnant, the thresholds are much lower. The American Thyroid Association recommends an upper TSH limit of 2.5 mIU/L in the first trimester and 3.0 mIU/L in the second and third trimesters. Levothyroxine is advised for pregnant women or those planning pregnancy whose TSH exceeds 2.5, especially if TPO antibodies are present.
These tighter cutoffs exist because even mild thyroid underperformance during pregnancy can affect fetal brain development and increase the risk of miscarriage and preterm birth. Women already on levothyroxine before pregnancy typically need their dose increased by 20 to 30 percent, and their TSH should be checked every four weeks through the first half of pregnancy.
Why the Threshold Shifts Higher With Age
TSH naturally rises as you get older. What looks like an abnormal reading in a 35-year-old may be perfectly normal for someone in their 70s. Overtreating mild TSH elevations in older adults can cause real harm: excess thyroid hormone increases the risk of irregular heart rhythms, bone loss, and fractures.
The American Thyroid Association suggests that for people aged 70 to 80, a target TSH of 4 to 6 mIU/L is appropriate, which is higher than the standard range used for younger adults. Treatment in this age group should start at low doses and increase gradually. For adults over 65, medication for subclinical hypothyroidism (TSH below 10) is generally not recommended unless there are clear, bothersome symptoms or other compelling reasons.
What Starting Treatment Looks Like
Levothyroxine is a once-daily pill taken on an empty stomach, typically first thing in the morning, 30 to 60 minutes before eating. For otherwise healthy adults, the starting dose is based on body weight: roughly 1.5 micrograms per kilogram per day. In practice, that’s around 75 to 100 micrograms for most women and 100 to 125 micrograms for most men. Older adults and anyone with heart disease start lower, usually 25 to 50 micrograms, and increase slowly.
After starting medication, your TSH is rechecked in about 6 to 8 weeks. Dose adjustments happen in small increments until your TSH falls into the target range, which for most adults is between 0.5 and 4.5 mIU/L. Once stable, you’ll typically get your TSH tested once or twice a year. Most people stay on levothyroxine long-term, though those who started medication for mild subclinical hypothyroidism sometimes taper off and recheck to see if their thyroid has stabilized on its own.
The Gray Zone: TSH 4.5 to 10
This range is where most of the uncertainty lives. You may feel perfectly fine with a TSH of 6, or you may feel exhausted and foggy. The challenge is that symptoms like fatigue and weight gain are extremely common in the general population and often have nothing to do with the thyroid. That’s why trials of people with TSH under 10 haven’t shown consistent symptom improvement with medication: many of them weren’t feeling bad because of their thyroid in the first place.
If your TSH falls in this gray zone and you have symptoms, a reasonable approach is a three- to six-month trial of levothyroxine. If your symptoms improve, that’s useful information. If they don’t, you and your doctor can reassess whether the medication is worth continuing. The key factors that tilt the decision toward treatment are positive TPO antibodies, a TSH that’s trending upward on repeat testing, cardiovascular risk factors, and age under 65 to 70.